Ketamine Completed Phase 4 Trials for Major Depressive Disorder (MDD) / Electroconvulsive Therapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00419003Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
NCT01870219Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy